The University of New South Wales

Subject Area Index

See LEGEND for key to shading and symbols.


Subject Area - PHAR  Term - Semester 2 2018

PHAR2011 PHAR3101 PHAR3202 PHAR3306 PHAR9104 PHAR9111
PHAR9115 PHAR9117 PHAR9120 PHAR9121 PHAR9124

Data is correct as at Tue Apr 24 18:01:01 AEST 2018


Comp Sect Class Type Status Enr/Cap % Full Times (weeks, Location) - default 1hour 
PHAR2011   Introductory Pharmacology and
LABM09A 4184EnrOpen5/100 5%   Mon 09-12 (w1-2,4,6,8,10,12, Wurth 115)
LABM09B 4185EnrOpen1/100 1%   Mon 09-12 (w1,3,5,7,9,11,13, Wurth 116)
LABM13A 4186EnrOpen6/100 6%   Mon 13-16 (w1-2,4,6,8,10,12, Wurth 115)
LECA 4175RelOpen12/300 4%   Wed 13 (w1-9,10-12, Rex Vowels); Fri 12 (w1-9,10-12, Rex Vowels)
TUTH11A 4176RelOpen4/40 10%   Thu 11 (w2-9,10-13, MorvB LG2)
TUTH11B 4177RelOpen0/40 0%   Thu 11 (w2-9,10-13, Mat 232)
TUTH12A 4178RelOpen3/40 8%   Thu 12 (w2-9,10-13, Mat 106)
TUTH12B 4179RelOpen2/40 5%   Thu 12 (w2-9,10-13, Mat 108)
TUTH15A 4180RelOpen2/40 5%   Thu 15 (w2-9,10-13, Mat 106)
TUTH15B 4181RelOpen0/40 0%   Thu 15 (w2-9,10-13, Mat 108)
TUTH16A 4182RelOpen1/40 3%   Thu 16 (w2-9,10-13, Mat 106)
TUTH16B 4183RelOpen0/40 0%   Thu 16 (w2-9,10-13, Mat 108)
PHAR3101   Drug Discovery, Design & Devel
LABT14A 5326EnrOpen17/60 28%   Tue 14-17 (Wurth 120)
LECA 5325RelOpen17/60 28%   Wed 11 (w1-9,10-12, WurthLG02); Thu 09 (w1-9,10-12, WurthLG02)
TUTW09A 5327RelOpen1/30 3%   Wed 09 (w2-9,10-13, AGSM LG06)
TUTW10A 5328RelOpen16/30 53%   Wed 10 (w2-9,10-13, AGSM LG06)
PHAR3202   Neuropharmacology
LABF10A 6610EnrOpen26/40 65%   Fri 10-13 (w2-9,10-13, Wurth 120)
LABF14A 6611EnrOpen3/40 8%   Fri 14-17 (w2-9,10-13, Wurth 120)
LECA 6609RelOpen29/80 36%   Tue 09 (w1-9,10-12, MathewsThD); Wed 14 (w1-9,10-12, MathewsThC)
TUTH12A 6612RelOpen19/40 48%   Thu 12 (w1-9,10-12, Mat 230)
TUTH13A 6613RelOpen10/40 25%   Thu 13 (w1-9,10-12, Mat 230)
PHAR3306   Pharmacology for Optometry
LABH15A 6615EnrOpen53/98 54%   Thu 15-18 (w8, Wurth 115); Thu 15-18 (w3,5,7,9,11,13, WurthG07)
LECA 6614RelOpen53/98 54%   Mon 14 (AinswthG02); Wed 16-18 (AinswthG02)
TUTH15B 6616RelFull33/33 100%   Thu 15 (w2,4,6,10,12, Webst 302)
TUTH16A 6617RelOpen20/33 61%   Thu 16 (w2,4,6,10,12, Webst 302)
TUTH17A 6618RelOpen0/33 0%   Thu 17 (w2,4,6,10,12, Webst 302)
PHAR9104   Regulatory Affairs
DSTA10025EnrOpen2/30 7%  
PHAR9111   Pharmaceutics
DSTA10026EnrOpen2/30 7%  
PHAR9115   Advanced HTA
DSTA10027EnrOpen0/30 0%  
PHAR9117   Cancer Therapeutics
DSTA10028EnrOpen2/30 7%  
PHAR9120   Clinical Trials
DSTA10029EnrOpen3/30 10%  
PHAR9121   Pharmacovigilance
DSTA10031EnrOpen1/30 3%  
PHAR9124   Internship
DSTA10030EnrOpen*0/5 0%  
^ top ^
LEGEND
* This class requires consent. Students cannot self-enrol.
# Timetable clash allowed.
/odd  Runs in odd weeks only.     /even  Runs in even weeks only.
Comb/w Jointly taught with corresponding class(es) for specified course(s). Capacity shown is effective capacity.
      Effective capacity is the class capacity less any places taken by students in the other jointly-taught classes.
[  ] Class capacity where different from effective capacity.
  
Shaded cells:  LEC Activity different from previous
Stop Status is Stop Further Enrolment, Tentative, Closed or Cancelled
100%   Class is full (> 100% means capacity is exceeded)
80%   Class is nearly full (80% or more)
50%   Class is half full
0%   Class is less than half full